John D. Isaacs - Concepedia

Author

John D. Isaacs

Also Known As

A G Wilson, A. G. Wilson, Ann Morgan, Ann W Morgan, BRAGGSS, Chris J. Edwards, D Vander Griend, D Walker, Darren Plant, David E. Jones

711

Publications

26.9K

Citations

H-Index

292

Concepts

All Affiliations

Newcastle University University of Leeds Newcastle upon Tyne Hospitals NHS Foundation Trust University of Manchester NIHR Leeds Musculoskeletal Biomedical Research Unit

About

John D. Isaacs is an author at Newcastle University specializing in medicine, immunology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	51	3.8K
2	Engineering	22	29	1.6K
3	Health Sciences	2	2	53
4	Natural Sciences	2	2	41
5	Arts	1	1	27

John D. Isaacs

227

Publications

18K

Citations

H-Index

Page 1

	Year	Citations
The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: A comparison with conventional radiography Richard J. Wakefield, Wayne Gibbon, Philip G. Conaghan, Arthritis & Rheumatism	2000	709
Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells Wan‐Fai Ng, Phillip J. Duggan, Frédérique Ponchel, Blood	2001	600
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis Joel M. Kremer, Zhanguo Li, Stephen Hall, Annals of Internal Medicine ImmunologyPharmacotherapyInflammatory ArthritisInflammationRheumatoid Disorder	2013	441
Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study Joanna Collerton, Carmen Martín-Ruiz, Karen Davies, Mechanisms of Ageing and Development InflammationAgingGeriatricsLongevityNewcastle 85+	2012	417
Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions Frédérique Ponchel, Carmel Toomes, Kieran Bransfield, BMC Biotechnology	2003	373
Integrated safety in tocilizumab clinical trials Michael Schiff, Joel M. Kremer, Angelika Jahreis, Arthritis Research & Therapy	2011	368
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) P. Emery, Atul Deodhar, William F. C. Rigby, Annals of the Rheumatic Diseases	2010	345
Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis Philip G. Conaghan, Philip O’Connor, Dennis McGonagle, Arthritis & Rheumatism	2003	344
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells Muzlifah Haniffa, Xiaonong Wang, Udo Holtick, The Journal of Immunology	2007	341
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial Iain B. McInnes, Joachim Sieper, Jürgen Braun, Annals of the Rheumatic Diseases	2013	339

Page 1